Detrusor overactivity is missed by stopping urodynamic investigation at a bladder volume of 500 mL.


Journal

BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 13 7 2019
medline: 2 6 2020
entrez: 13 7 2019
Statut: ppublish

Résumé

To investigate whether detrusor overactivity (DO) is missed in a relevant percentage of patients if the urodynamic investigation (UDI) is stopped at a filling volume of 500 mL due to the fear of bladder overdistention, in patients with lower urinary tract symptoms and high bladder capacity. A consecutive series of 1598 patients with a bladder capacity of >500 mL in the bladder diary undergoing UDI due to lower urinary tract dysfunction (LUTD) was prospectively investigated. UDI was performed according to Good Urodynamic Practices recommended by the International Continence Society. UDI was stopped at strong desire to void or in case of autonomic dysreflexia, vesico-uretero-renal reflux, bladder pain or discomfort. Of the 1598 patients (594 women, 1004 men), 1282 (80%) and 316 (20%) had neurogenic and non-neurogenic LUTD, respectively. Overall, DO was detected in 66% (1048/1598), in 71% (910/1282) with neurogenic and in 44% (138/316) with non-neurogenic LUTD. DO occurred in 16% (263/1598, 95% confidence interval [CI] 14.7-18.4%) only at a bladder volume >500 mL. This phenomenon was significantly (P < 0.001) more frequent in patients with neurogenic (18% [236/1282], 95% CI 16.4-20.6%) compared with non-neurogenic (9% [27/316], 95% CI 5.9-12.1%) LUTD. In both neurological and non-neurological patients with high bladder capacity, we strongly recommend not to stop UDI at a bladder volume of 500 mL, as DO might be missed in a relevant percentage leading to inappropriate patient treatment.

Identifiants

pubmed: 31298777
doi: 10.1111/bju.14868
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

870-875

Informations de copyright

© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.

Références

Rosier P, Schaefer W, Lose G et al. International continence society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn 2017; 36: 1243-60
Gammie A, Clarkson B, Constantinou C et al. International Continence Society guidelines on urodynamic equipment performance. Neurourol Urodyn 2014; 33: 370-9
Madersbacher H, Cardozo L, Chapple C et al. What are the causes and consequences of bladder overdistension? ICI-RS 2011. Neurourol Urodyn 2012; 31: 317-21
Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol 2015; 14: 720-32
Defreitas GA, Zimmern PE, Lemack GE, Shariat SF. Refining diagnosis of anatomic female bladder outlet obstruction: comparison of pressure-flow study parameters in clinically obstructed women with those of normal controls. Urology 2004; 64: 675-9
Bellucci CH, Wöllner J, Gregorini F et al. Neurogenic lower urinary tract dysfunction-do we need same session repeat urodynamic investigations? J Urol 2012; 187: 1318-23
Walter M, Knüpfer SC, Leitner L et al. Autonomic dysreflexia and repeatability of cardiovascular changes during same session repeat urodynamic investigation in women with spinal cord injury. World J Urol 2016; 34: 391-7
Walter M, Knüpfer SC, Cragg JJ et al. Prediction of autonomic dysreflexia during urodynamics: a prospective cohort study. BMC Med 2018; 16: 53. https://doi.org/10.1186/s12916-018-1040-8.
Purohit RS, Blaivas JG, Saleem KL et al. The pathophysiology of large capacity bladder. J Urol 2008; 2008: 1006-11
Shimizu S, Saito M, Kinoshita Y et al. Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger. BJU Int 2009; 104: 713-7
Bratslavsky G, Kogan BA, Matsumoto S, Aslan AR, Levin RM. Reperfusion injury of the rat bladder is worse than ischemia. J Urol 2003; 170: 2086-90
Li WJ, Shin MK, Oh SJ. Time dependent bladder apoptosis induced by acute bladder outlet obstruction and subsequent emptying is associated with decreased MnSOD expression and Bcl-2/Bax ratio. J Korean Med Sci 2010; 25: 1652-6
Van Poppel H, Stessens R, Van Damme B, Carton H, Baert L. Diabetic cystopathy: neuropathological examination of urinary bladder biopsies. Eur Urol 1988; 15: 128-31
Steers WD, Mackway-Gerardi AM, Ciambotti J, de Groat WC. Alterations in neural pathways to the urinary bladder of the rat in response to streptozotocin-induced diabetes. J Auton Nerv Syst 1994; 47: 83-94
Sasaki K, Chancellor MB, Phelan MW et al. Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root ganglia. J Urol 2002; 168: 1259-64
Dunn M. A study of the bladder blood flow during distension in rabbits. Br J Urol 1975; 47: 67-72
Orsola A, Adam RM, Peters CA, Freeman MR. The decision to undergo DNA or protein synthesis is determined by the degree of mechanical deformation in human bladder muscle cells. Urology 2002; 59: 779-83
Changolkar AK, Hypolite JA, Disanto M, Oates PJ, Wein AJ, Chacko S. Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol 2005; 173: 309-13
Collins CW, Winters JC, American Urological A, Society of Urodynamics Female Pelvic Medicine and Urogenital Reconstruction. AUA/SUFU adult urodynamics guideline: a clinical review. Urol Clin North Am 2014; 41: 353-62, vii
Groen J, Pannek J, Castro Diaz D et al. Summary of European Association of Urology (EAU) guidelines on neuro-urology. Eur Urol 2016; 69: 324-33
Kessler TM. Diagnosis of urinary incontinence. JAMA 2008; 300: 283
Musco S, Padilla-Fernández B, Del Popolo G et al. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: a systematic review. Neurourol Urodyn 2018; 37: 1522-40

Auteurs

Philipp Baumeister (P)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Department of Urology, Cantonal Hospital Luzern, Luzern, Switzerland.

Marko Kozomara (M)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Department of Urology, University Hospital Zürich, Zürich, Switzerland.

Burkhardt Seifert (B)

Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland.

Ulrich Mehnert (U)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.

Thomas M Kessler (TM)

Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH